Design (Testphase)
Growth
William O'Neil (CAN SLIM)
13
Hits
August 3, 2026
last calculated
Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
O'Neil's CAN SLIM criteria ('How to Make Money in Stocks'), quantitative core: quarterly EPS and revenue each ≥ +25% (C), EPS rating ≥ 80 as evidence of multi-year earnings history (A), no more than 10% below the 52-week high (N), RS rating ≥ 80 (L), and more fund buyers than sellers in the last quarter (I). The qualitative points (new products, market direction) are checked by the investor themself, as in the original. Source: fundamental data.
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
🔔 Watch scanner
Terms in This Scanner Explained
(18)
- 52-Week High / Low
- The highest or lowest price of the last 52 weeks (one trading year). "Within 10% of the 52-week high" means: the stock is trading near its yearly high - a sign of strength, since weakness looks different.
- ADR (Average Daily Range)
- The average daily swing of a stock in percent - measured over 10 or 30 trading days (columns "ADR 10D/30D"). An ADR of 5% means: on a normal day the gap between the intraday low and high runs about 5%. Traders look for movement - that is why stocks with an ADR under 1% are filtered out globally. Not to be confused with ADR meaning "American Depositary Receipt" (a US certificate for foreign shares) - here ADR always means the daily swing.
- AI Classification
- Our company-by-company assessment of the AI boom based on SEC filings (the last four quarterly 10-Q reports and two annual 10-K reports): "Sells AI" (AI is a revenue source), "Threatened" (AI is a concrete business risk), "Uses AI" (operational use), or "Neutral" (no material AI exposure). Every classification requires at least two direct quote citations - otherwise the column shows "-". Not a quality judgment or a buy recommendation; the full file is on the stock page, methodology at /stocks/ai-rating-methodology.
- Analysis (Full Company Analysis)
- If the Analysis column shows "Read," there is an in-depth TickerGuard company analysis for this stock: business model, scanner findings, quarterly results, evidence from SEC filings, plus opportunities and risks. One click opens it directly.
- Avg/Yr 3Y (Average Annual Return)
- The stock's average annual return over the past 3 years. Shows at a glance whether a stock delivers over the long run or just had a short hot streak.
- CANSLIM
- William O'Neil's strategy framework, whose seven letters each mark a criterion - among them current earnings growth, new products/highs, institutional sponsorship, and market direction. Core idea: buy the market leaders, not the laggards.
- Earnings Date
- The date of the next quarterly earnings report. Price gaps in either direction are common around this date - that is why we color it red when it is 7 days away or less, and yellow when it is 14 days away or less: elevated risk for fresh positions.
- EPS (Earnings per Share)
- Quarterly earnings divided by the number of shares outstanding. The most important growth metric: if EPS rises strongly over several quarters, the company is earning more money per share.
- Free Cash Flow (FCF)
- Operating cash flow minus capital expenditures - the money left over for everything else (debt paydown, acquisitions, or buybacks). Consistently positive free cash flow is one of the most honest signs of a healthy business model.
- Funda Rating (Fundamental Rating A+ to F)
- Our proprietary fundamental rating from 0 to 100 points with a school-grade rank from A+ to F. 50 points is the average across the universe, 100 the best possible score. Every stock is scored against all others by percentile: growth in earnings and revenue, earnings surprises, analyst estimates, and quality criteria such as margins, cash flow, and balance-sheet strength. Grades: A+ from 95, A from 75, B from 55, C from 45, D from 25, E from 5, F below — A/A+ are the fundamentally strongest stocks in the universe.
- Market Capitalization (Mkt Cap)
- The market value of the company: share price x total shares outstanding, shown here in billions of dollars. Micro caps (< $0.3B) are small and volatile, mega caps (> $200B) are heavyweights. Our scanner universe is deliberately capped at $50B - we look for stocks with room to run.
- Net Margin
- How much of revenue is left as profit? Net income divided by revenue, in percent. A 20% margin means: out of every dollar of revenue, 20 cents is left as profit. Rising margins are a strong quality signal.
- Operating Cash Flow (OCF)
- The cash that actually flows into the company from day-to-day operations - without accounting effects such as depreciation. A company can report book profits while still burning cash; operating cash flow reveals that.
- Piotroski F-Score
- A balance-sheet health check developed by Joseph Piotroski: 9 yes/no criteria covering earnings, cash flow, leverage, and efficiency produce a score from 0 to 9. Scores of 7 or higher are considered financially very solid, scores under 3 a warning sign.
- Relative Strength (RS Rating)
- How much has a stock risen compared with every other stock? The RS Rating is a percentile from 1 to 99: RS 90 means the stock has outperformed 90% of all stocks (depending on the scanner, over 1 week, 1, 3, 6, or 12 months). Market leaders almost always carry high RS values - that is why relative strength is the core of many momentum strategies.
- Sector & Industry
- Two levels of industry classification: sector is broad (e.g., Technology), industry is narrow (e.g., Semiconductors). Many strategies watch industry strength, because strong stocks are almost always found in strong industries.
- Stage (Weinstein Stages 1-4)
- Stan Weinstein divides every price chart into four stages: Stage 1 = basing (sideways after a downtrend), Stage 2 = uptrend (the only buying stage), Stage 3 = topping, Stage 4 = downtrend (avoid, or short candidate). Measured against the 30-week line (150-day moving average) and its slope.
- Stress RS (Strength on Stress Days)
- A stress day is a day on which both the overall market and the stock's own sector fell at least 0.5%. Stress RS counts on how many of these days the stock still closed green (shown as "g/n" = green days out of n stress days) and turns that into a rating from 1 to 99. High values point to buyers stepping in even on weak days - often a sign of institutional accumulation.
Hit List
Filter ▾
Rating (traffic light)
Stage
Funda Rating
Piotroski
Columns ▾
This scanner's columns
Extra columns
Tip: clicking a column header sorts the table by that column; a second click flips the direction.
| Symbol | Earnings | Avg/Y 3Y | Stress RS | Stage | Funda Rating | Piotroski | MktCap | Industry | AI Rating | Deep Dive | Deep-Dive Report | Sector | Price | YTD | 6 Mo. | 1 Year | Off High | Price Target | RS | EPS Rating | ADR 10D | ADR 30D | Beta | P/E | P/E (f) | P/S | P/B | P/FCF | PEG | EV/EBITDA | EBIT Margin | Gross Margin | Net Margin | ROE | ROA | Debt/Eq | Equity Ratio | Sales +/Y | Growth Score | Div. Yield | Payout Ratio | Altman Z | Inst. % | Short % | Analysts |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ATEX Anterix Inc | 08/11 | +51 % | 89 9/24 | Stage 2 | A 78 | 7 of 9 | 1.8 $ | Telecom Services | Neutral | — | Communication Services | 93.00 $ | +266.4 % | +339.9 % | +318.8 % | −8.1 % | +15.8 % | 97 | 85 | 8.3 % | 8.2 % | 0.83 | 21.3 | 0.0 | 266.2 | 7.7 | 319.5 | — | -12.4 | — | 100.0 % | 1,394.2 % | 43.3 % | -6.5 % | 0.02 | — | +7.8 % | — | 0.0 % | 0.0 % | 3.5 | 91.8 % | 16.9 % | 4.7 (3) | |
| AGX Argan Inc | — | +629 % | 85 10/29 | Stage 2 | A 78 | 5 of 9 | 8.6 $ | Engineering & Construction | Uses AI | — | — | Industrials | 570.40 $ | +135.6 % | +141.6 % | +134.0 % | −4.8 % | +19.2 % | 96 | 86 | 7.0 % | 7.0 % | 0.56 | 50.9 | 16.6 | 8.2 | 16.9 | 17.6 | — | 43.3 | 15.6 % | 20.7 % | 15.5 % | 38.5 % | 9.4 % | — | 36.8 % | +8.1 % | — | 0.4 % | 17.6 % | 8.1 | 108.9 % | 6.7 % | 4.0 (2) |
| BTSG BrightSpring Health Services, Inc. | 08/07 | — | 88 8/22 | Stage 2 | B 73 | 8 of 9 | 11.8 $ | Health Information Services | Uses AI | — | Healthcare | 59.70 $ | +78.5 % | +82.8 % | +189.2 % | −0.2 % | +31.5 % | 94 | 94 | 3.0 % | 3.3 % | 1.80 | 76.7 | 32.8 | 0.8 | 5.9 | 29.3 | — | 22.3 | 3.4 % | 12.4 % | 2.6 % | 9.2 % | 4.9 % | -4.87 | 31.9 % | +14.6 % | — | 0.0 % | 0.0 % | 5.5 | 101.5 % | 7.9 % | 4.7 (12) | |
| OSCR Oscar Health Inc | 08/05 | +84 % | 79 7/22 | Stage 2 | B 64 | 7 of 9 | 9.0 $ | Healthcare Plans | Uses AI | — | — | Healthcare | 31.20 $ | +108.3 % | +97.3 % | +122.2 % | −5.6 % | -19.2 % | 94 | 87 | 5.6 % | 6.6 % | 2.34 | — | 588.2 | 0.7 | 5.7 | 3.2 | — | 0.0 | 15.2 % | 17.4 % | -0.3 % | -2.6 % | 0.1 % | 0.26 | 17.9 % | +27.5 % | — | 0.0 % | 0.0 % | 3.0 | 67.6 % | 8.0 % | 3.3 (7) |
| NESR National Energy Services Reunited Corp. | 08/19 | +252 % | 56 2/10 | Stage 2 | B 64 | 7 of 9 | 2.7 $ | Oil & Gas Equipment & Services | Neutral | — | Energy | 27.00 $ | +60.1 % | +89.1 % | +304.2 % | −2.6 % | +22.2 % | 94 | 87 | 5.7 % | 5.1 % | 0.32 | 43.3 | 0.0 | 1.9 | 2.7 | 21.7 | — | 11.8 | 8.9 % | 12.5 % | 4.5 % | 6.7 % | 3.8 % | 0.31 | 51.7 % | +1.7 % | — | 0.0 % | 0.0 % | 5.0 | 85.2 % | 6.2 % | 4.3 (3) | |
| TGTX TG Therapeutics Inc | 08/03 | +43 % | 53 5/22 | Stage 2 | B 68 | 5 of 9 | 8.0 $ | Biotechnology | Neutral | — | Healthcare | 52.00 $ | +80.9 % | +79.3 % | +46.6 % | −6.5 % | +31.6 % | 90 | 92 | 5.0 % | 4.8 % | 1.60 | 18.9 | 55.2 | 11.5 | 14.2 | — | 1.61 | 54.6 | 17.0 % | 83.1 % | 66.0 % | 112.6 % | 8.6 % | 1.29 | 38.1 % | +87.3 % | — | 0.0 % | 0.0 % | 6.2 | 70.2 % | 29.0 % | 4.3 (9) | |
| VIRT Virtu Financial, Inc. | 07/29 | +98 % | 96 10/22 | Stage 2 | B 55 | 3 of 9 | 12.6 $ | Capital Markets | – | — | — | Financial Services | 58.70 $ | +92.3 % | +74.0 % | +36.2 % | −5.9 % | +13.7 % | 89 | 83 | 4.6 % | 3.8 % | 0.58 | 9.7 | 9.8 | 3.1 | 2.9 | 26.1 | — | 6.4 | 46.8 % | 65.8 % | 16.9 % | 56.9 % | 4.5 % | 2.68 | 6.9 % | +26.3 % | — | 1.6 % | 14.6 % | 4.7 | 92.4 % | 5.8 % | 3.3 (9) |
| ASTH Astrana Health Inc | 08/06 | +13 % | 70 6/22 | Stage 2 | B 62 | 5 of 9 | 1.8 $ | Medical Care Facilities | Uses AI | — | Healthcare | 35.60 $ | +66.1 % | +79.3 % | +49.0 % | −0.5 % | +38.6 % | 89 | 87 | 3.6 % | 3.8 % | 0.89 | — | 23.0 | 0.5 | — | 11.4 | — | 14.4 | 3.0 % | 10.7 % | 0.9 % | 5.7 % | 3.6 % | — | 33.9 % | +56.4 % | — | 0.0 % | 0.0 % | 5.2 | 61.5 % | 10.3 % | 4.5 (12) | |
| AMN AMN Healthcare Services Inc | 08/06 | -23 % | 93 9/22 | Stage 2 | B 59 | 8 of 9 | 1.3 $ | Medical Care Facilities | Threatened | — | Healthcare | 33.60 $ | +98.2 % | +102.2 % | +83.4 % | −2.4 % | -5.2 % | 89 | 93 | 4.9 % | 5.2 % | 0.42 | — | 26.2 | 0.4 | — | 1.8 | 1.71 | 7.5 | — | 27.6 % | -1.0 % | -4.5 % | 3.5 % | — | — | -8.5 % | — | 0.0 % | 0.0 % | 5.6 | 115.6 % | 11.1 % | 3.3 (9) | |
| PTGX Protagonist Therapeutics Inc | 08/05 | +110 % | 53 5/22 | Stage 2 | C 47 | 6 of 9 | 8.8 $ | Biotechnology | – | — | — | Healthcare | 136.60 $ | +36.2 % | +36.9 % | +153.7 % | −2.8 % | -2.4 % | 87 | 94 | 4.2 % | 4.5 % | 1.79 | — | 28.9 | 118.4 | 13.4 | — | — | 244.6 | -6.5 % | 100.0 % | -154.9 % | -17.1 % | -12.4 % | 0.02 | 94.0 % | -89.4 % | — | 0.0 % | 0.0 % | 21.8 | 125.3 % | 15.0 % | 4.4 (10) |
| RSI Rush Street Interactive Inc | 07/29 | +294 % | 51 7/31 | Stage 2 | B 71 | 6 of 9 | 6.4 $ | Gambling | Uses AI | — | Consumer Cyclical | 26.90 $ | +51.9 % | +63.0 % | +33.5 % | −2.2 % | +33.8 % | 86 | 81 | 4.7 % | 4.0 % | 1.56 | 77.7 | 43.5 | 4.7 | 17.1 | 37.7 | — | 13.6 | 11.6 % | 35.0 % | 2.3 % | 34.7 % | 12.8 % | 0.04 | 23.5 % | +22.8 % | — | 0.0 % | 0.0 % | 5.4 | 100.5 % | 9.6 % | 4.9 (7) | |
| DAVE Dave Inc | 08/05 | +2,117 % | 61 6/25 | Stage 2 | A 84 | 6 of 9 | 4.7 $ | Software - Application | Uses AI | — | Technology | 372.70 $ | +43.6 % | +62.5 % | +58.1 % | −5.8 % | +4.5 % | 83 | 86 | 8.5 % | 8.1 % | 3.83 | — | 22.7 | 7.8 | — | 14.4 | — | 22.1 | 38.3 % | 72.1 % | 37.2 % | 111.6 % | 32.0 % | — | 38.4 % | +59.7 % | — | 0.0 % | 0.0 % | 11.6 | 100.1 % | 21.0 % | 4.8 (8) | |
| CXW CoreCivic Inc | 08/05 | +72 % | 85 10/29 | Stage 2 | B 64 | 7 of 9 | 2.9 $ | Security & Protection Services | – | — | — | Industrials | 29.90 $ | +55.6 % | +58.6 % | +49.2 % | −4.5 % | +21.7 % | 83 | 81 | 4.2 % | 4.0 % | 0.57 | 25.5 | 19.0 | 1.3 | 2.2 | 112.9 | 1.06 | 11.1 | 11.4 % | 23.6 % | 5.5 % | 9.0 % | 4.8 % | 1.00 | 41.4 % | +12.7 % | — | 0.0 % | 0.0 % | 5.3 | 91.6 % | 2.7 % | 5.0 (4) |
Price Chart
Quarterly Figures
No quarterly data available.
Frequently Asked Questions
O'Neil's CAN SLIM criteria ('How to Make Money in Stocks'), quantitative core: quarterly EPS and revenue each ≥ +25% (C), EPS rating ≥ 80 as evidence of multi-year earnings history (A), no more than 10% below the 52-week high (N), RS rating ≥ 80 (L), and more fund buyers than sellers in the last quarter (I).
All scanners are recalculated daily across the entire stock universe — most recently on 3. August 2026. The data basis is fundamental data and SEC filings (10-K annual reports and 10-Q quarterly reports).
Currently, 13 stocks pass this scanner's criteria (as of 3. August 2026).
Global filters: market cap of $50B or less (mega caps are cut from every scanner); 10- and 30-day ADR must be ≥ 1% (too little movement gets cut); names after a reverse split (distorted price history) and names with a red Stress RS (rating ≤ 30 — weak on stress days) are excluded.
Related scanners
- Ben Bennett: Focus List
- Ben Bennett: Power Screen
- Dan Zanger: Leader
- EPS & Revenue Power
- EPS Acceleration
- High Revenue Growth
- Jim Roppel: 20/20 Screen
- Joshua
- Martin Zweig: Growth with Reason
- Matt Caruso: Sales Leader
- Patrick Walker: 30% EPS Growth
- Patrick Walker: 40, 40 Screen
- Quality Growth
- Small Caps with Growth
- Ted Zhang: Super Stock Universe
- Thomas' Favorites
- Triple-Digit Revenue Growth
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.